These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27713154)

  • 1. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
    Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
    Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
    Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
    Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
    Li D; Wang H; Ding Y; Zhang Z; Zheng Z; Dong J; Kim H; Meng X; Zhou Q; Zhou J; Fang L; Shen Q
    Cancer Lett; 2018 Jun; 424():97-108. PubMed ID: 29580806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 regulates cell motility through RhoA-ROCK1 signalling in non-small-cell lung cancer cells.
    Ko E; Kim D; Min DW; Kwon SH; Lee JY
    Sci Rep; 2021 Jan; 11(1):1247. PubMed ID: 33441941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
    Teo CR; Casey PJ; Rasheed SA
    Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway.
    Yan L; Li H; An W; Wei W; Zhang X; Wang L
    Bioengineered; 2021 Dec; 12(1):5850-5858. PubMed ID: 34486491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ODAM inhibits RhoA-dependent invasion in breast cancer.
    Lee HK; Choung HW; Yang YI; Yoon HJ; Park IA; Park JC
    Cell Biochem Funct; 2015 Oct; 33(7):451-61. PubMed ID: 26358398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.
    Liu X; Chen D; Liu J; Chu Z; Liu D
    Technol Cancer Res Treat; 2017 Oct; 16(5):630-638. PubMed ID: 27609633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A; Hashemy SI; Aghaei M; Panjehpour M
    Cell Signal; 2017 Apr; 32():104-114. PubMed ID: 28104444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway.
    Cao XX; Xu JD; Xu JW; Liu XL; Cheng YY; Li QQ; Xu ZD; Liu XP
    Breast Cancer Res Treat; 2011 Apr; 126(3):555-63. PubMed ID: 20499158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen increases Nrf2 activity through activation of the PI3K pathway in MCF-7 breast cancer cells.
    Wu J; Williams D; Walter GA; Thompson WE; Sidell N
    Exp Cell Res; 2014 Nov; 328(2):351-60. PubMed ID: 25172557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.
    Jiang J
    Biomed Pharmacother; 2017 Oct; 94():439-445. PubMed ID: 28779705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated metabolic reprogramming.
    Zhang HS; Du GY; Zhang ZG; Zhou Z; Sun HL; Yu XY; Shi YT; Xiong DN; Li H; Huang YH
    Int J Biochem Cell Biol; 2018 Feb; 95():85-92. PubMed ID: 29275212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J; Gao P; Xu Y; Li Z
    Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol induces endothelial cell migration and proliferation through estrogen receptor-enhanced RhoA/ROCK pathway.
    Oviedo PJ; Sobrino A; Laguna-Fernandez A; Novella S; Tarín JJ; García-Pérez MA; Sanchís J; Cano A; Hermenegildo C
    Mol Cell Endocrinol; 2011 Mar; 335(2):96-103. PubMed ID: 20615453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231.
    Meng C; Song L; Wang J; Li D; Liu Y; Cui X
    Oncol Rep; 2017 Feb; 37(2):841-848. PubMed ID: 28035403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
    Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
    Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.